• News
  • Health Care

FDA greenlights first nonopioid drug for opioid withdrawal

FDA greenlights first nonopioid drug for opioid withdrawal

"The actions of norepinephrine in the autonomic nervous system are believed to play a role in numerous symptoms of opioid withdrawal", the FDA said.

Lucemyra, an oral selective alpha 2-adrenergic receptor agonist, limits the body's output of norepinephrine, the hormone believed to play a role in symptoms of opioid withdrawal, the FDA said. Specifically, the studies will investigate the safety of Lucemyra in situations where use may last beyond the 14-day recommended treatment period, as well as what the effects may be on blood pressure after the treatment is discontinued.

"The FDA will continue to encourage the innovation and development of therapies to help those suffering from opioid addiction transition to lives of sobriety, as well as address the unfortunate stigma that's sometimes associated with the use of medication-assisted treatments", Dr. Gottlieb said. Less common reactions could include fainting and abnormal heart rhythms.

The safety and efficacy of Lucemyra have not been established in children or adolescents under age 17. This was a patient-reported outcome instrument that could help patients report their symptoms after intake of the drug.

"The fear of experiencing withdrawal symptoms often prevents those suffering from opioid addiction from seeking help".

The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom withdrawal symptoms in adults in whom the drugs have been withdrawn abruptly. If the score was higher the symptoms of withdrawal was deemed higher. The symptoms can inflict patients who are using opioids as instructed by a physician, and those patients who are addicted to it.

Opioid withdrawal incorporates indications for example - uneasiness, unsettling, rest issues, muscle hurts, runny nose, sweating, sickness, spewing, loose bowels and medication wanting - that happens in the wake of ceasing or lessening the utilization of opioids in anybody with physical reliance on opioids.

Use of lofexidine should be part of a long-term treatment plan for patients stopping opioids when physically dependent, the FDA and US WorldMeds indicated. The FDA also points out that these symptoms can arise in patients who are taking opioid painkillers appropriately, as well as those with opioid use disorder. "We're developing new guidance to help accelerate the development of better treatments, including those that help manage opioid withdrawal symptoms". Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them.

Manufacturer US WorldMeds said it will market the drug as soon as this summer, under the trade name Lucemyra. "I applaud the work of the FDA as well as the National Institute on Drug Abuse, which supported clinical studies of the treatment, in prioritizing efforts to prevent and treat opioid addiction".

The FDA granted Lucemyra the go-ahead after previous priority review and fast track designations, and it comes after an independent scientific panel voted 11-1 in favor of its approval.

Leave Your Comment

Leave Your Comment


Latest News

Breaking News



Recommended

School Bus Crash in New Jersey Kills At Least 2, Reports Say

Two other buses not involved in the accident returned to the school, and students were dismissed early. At about 12:30 p.m., state police brought in K-9s to search the woods and areas near the scene.

U.S. regulators begin Tesla crash investigations

Interested in solar? Get a solar cost estimate and find out how much a solar system would cost for your home or business. The aftermath of the Tesla Model S crash in Utah. "An impact at that speed usually results in severe injury or death".

Trump on North Korea summit: 'We'll have to see'

She added the annual exercises are long-planned, defensive in nature and meant to ensure the readiness of USA and South Korean forces.

Mothercare confirms 50 closures in rescue plan

Richard Lim, chief executive, Retail Economics said: "This is turning out to be a year of distress for the retail sector". Reports suggested Mr Whiley had been a key player in pulling together a rescue deal and forming the restructuring plans.

Meet Prince Harry and Meghan Markle's Wedding Party

Thousands of journalists from across the world are descending on the genteel town of Windsor for the wedding , and Mr. They have often featured on each other's Instagram profile. "Meghan and I do not have a relationship now".

NY lawyer threatens to call ICE on women for speaking Spanish

The video went viral instantly, appearing on Gothamist before being picked up by BBC News , the New York Times , and USA Today . Backlash to the video, which was posted on activist Shaun King's twitter account, was swift and fierce.

Eagles Schedule White House Visit, Though Not All Are Coming

Jenkins said. "If you want to meet to talk about events in my community, changing the country, I'm all for that. Over the last two years I have been meeting with legislators, both republican and democrat.

Canada 'Positive' on NAFTA, Mexico Says Deal Possible by End-May

There's also the looming matter of steel and aluminum tariffs, scheduled to kick in June 1 unless the US extends them. The countries remain divided on key issues like auto sector rules, a sunset clause and dispute settlement panels.

US Senate confirms Gina Haspel to lead Central Intelligence Agency

Haspel, who will be the first woman director of the CIA , is a 33-year veteran at the agency now serving as its acting director. As she rose up the ranks, she said she experienced some resistance from the male-heavy ranks of the spy corps.

Will Cong-JD(S) MLAs stay at Kerala resort owned by Left MLA?

He requested that the current government here should be dissolved and the single largest party, RJD, be invited to form the government.